Literature DB >> 20326386

Physiological Availability of Dicumarol.

E Lozinski.   

Abstract

Entities:  

Year:  1960        PMID: 20326386      PMCID: PMC1938513     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


× No keyword cloud information.
  4 in total

1.  The relation between in vitro disintegration time of sugar-coated tablets and physiological availability of sodium p-aminosalicylate.

Authors:  D G CHAPMAN; R CRISAFIO; J A CAMPBELL
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1956-06

2.  Reliability of the riboflavin excretion technique in determining availability of coated tablets.

Authors:  D G CHAPMAN; J A CAMPBELL
Journal:  Can J Biochem Physiol       Date:  1955-09

3.  Physiological availability of drugs in tablets.

Authors:  J A CAMPBELL; D G CHAPMAN; L G CHATTEN
Journal:  Can Med Assoc J       Date:  1957-01-15       Impact factor: 8.262

4.  The relation between in vitro disintegration time of sugar-coated tablets and physiological availability of riboflavin.

Authors:  D G CHAPMAN; R CRISAFIO; J A CAMPBELL
Journal:  J Am Pharm Assoc Am Pharm Assoc       Date:  1954-05
  4 in total
  5 in total

1.  [Editorial: Definition of the concepts availments and availability].

Authors:  F H Dost
Journal:  Klin Wochenschr       Date:  1975-02-15

2.  Some implications of legalized substitution of prescribed pharmaceuticals.

Authors:  J M PARKER
Journal:  Can Med Assoc J       Date:  1962-12-22       Impact factor: 8.262

3.  Clinical significance of generic inequivalence of three different pharmaceutical preparations of phenytoin.

Authors:  L Lund
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

4.  Scientific principles in design of drug dosage formulations.

Authors:  S S Davis
Journal:  Br Med J       Date:  1972-01-08

5.  Comparison of a new microcrystalline dicoumarol preparation with warfarin under routine treatment conditions.

Authors:  D Lockner; C Paul
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.